Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
2.310
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT

Aptose Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5132053122390
Upgrade
Market Cap Growth
-33.27%-33.27%-62.12%-56.27%-68.80%-9.61%
Upgrade
Enterprise Value
10163-327252
Upgrade
Last Close Price
2.316.7676.20261.00607.501971.00
Upgrade
PB Ratio
-1.11-2.96-6.941.411.643.28
Upgrade
P/TBV Ratio
---1.411.643.28
Upgrade
Debt / Equity Ratio
-2.34-2.34-0.350.040.010.01
Upgrade
Quick Ratio
1.381.380.613.829.6817.97
Upgrade
Current Ratio
2.142.140.784.0310.0018.36
Upgrade
Return on Equity (ROE)
---293.95%-74.70%-67.67%-51.91%
Upgrade
Return on Assets (ROA)
-141.99%-141.99%-102.23%-39.87%-39.18%-30.75%
Upgrade
Return on Capital (ROIC)
-779.60%-779.60%-176.13%-46.77%-42.00%-32.36%
Upgrade
Earnings Yield
-506.35%-189.15%-254.17%-78.63%-53.73%-14.17%
Upgrade
FCF Yield
-716.46%-267.63%-221.47%-60.81%-35.77%-8.71%
Upgrade
Buyback Yield / Dilution
-210.44%-210.44%-9.81%-3.57%-8.86%-63.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.